TW200635590A - Stable granular pharmaceutical composition of solifenacin or its salt - Google Patents

Stable granular pharmaceutical composition of solifenacin or its salt

Info

Publication number: TW200635590A
Authority: TW; Taiwan
Prior art keywords: solifenacin; salt; pharmaceutical composition; granular pharmaceutical; granular
Prior art date: 2004-12-27

Application number

TW094146775A

Other languages

English (en)

Chinese (zh)

Inventor

Hiroyuki Umejima

Hiroshi Ohi

Katsumi Saitou

Yuko Taketani

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-27

Filing date

2005-12-27

Publication date

2006-10-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40283425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200635590(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-27 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2006-10-16 Publication of TW200635590A publication Critical patent/TW200635590A/zh

Links

FBOUYBDGKBSUES-VXKWHMMOSA-N solifenacin Chemical group C1([C@H]2C3=CC=CC=C3CCN2C(O[C@@H]2C3CCN(CC3)C2)=O)=CC=CC=C1 FBOUYBDGKBSUES-VXKWHMMOSA-N 0.000 title abstract 5
229960003855 solifenacin Drugs 0.000 title abstract 5
239000008194 pharmaceutical composition Substances 0.000 title abstract 4
150000003839 salts Chemical class 0.000 title abstract 4
239000000203 mixture Substances 0.000 abstract 3
230000032683 aging Effects 0.000 abstract 1
239000011230 binding agent Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
238000002425 crystallisation Methods 0.000 abstract 1
230000008025 crystallization Effects 0.000 abstract 1
238000000354 decomposition reaction Methods 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

TW094146775A 2004-12-27 2005-12-27 Stable granular pharmaceutical composition of solifenacin or its salt TW200635590A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US63838804P	2004-12-27	2004-12-27
JP2005085968		2005-03-24

Publications (1)

Publication Number	Publication Date
TW200635590A true TW200635590A (en)	2006-10-16

Family

ID=40283425

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW094146775A TW200635590A (en)	2004-12-27	2005-12-27	Stable granular pharmaceutical composition of solifenacin or its salt

Country Status (10)

Country	Link
JP (1)	JP4636445B2 (cs)
BG (1)	BG1677U1 (cs)
BR (1)	BRPI0519270A2 (cs)
CZ (1)	CZ23089U1 (cs)
ES (1)	ES2387571T3 (cs)
IL (1)	IL183877A0 (cs)
MX (1)	MX2007007911A (cs)
RU (1)	RU2397767C2 (cs)
SK (1)	SK6196Y1 (cs)
TW (1)	TW200635590A (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20140303254A1 (en) *	2013-04-08	2014-10-09	InnoPharma Licensing LLC	Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO2005012I1 (no) *	1994-12-28	2005-06-06	Debio Rech Pharma Sa	Triptorelin og farmasoytisk akseptable salter derav
CN100355419C (zh) *	2002-06-07	2007-12-19	安斯泰来制药有限公司	治疗膀胱过度活动的药物
JP4523265B2 (ja) *	2002-11-13	2010-08-11	旭化成ファーマ株式会社	排尿障害治療用口腔内崩壊製剤

2005
- 2005-12-26 BR BRPI0519270-6A patent/BRPI0519270A2/pt not_active IP Right Cessation
- 2005-12-26 CZ CZ201124173U patent/CZ23089U1/cs not_active IP Right Cessation
- 2005-12-26 RU RU2007128815/15A patent/RU2397767C2/ru not_active IP Right Cessation
- 2005-12-26 ES ES05820232T patent/ES2387571T3/es not_active Expired - Lifetime
- 2005-12-26 MX MX2007007911A patent/MX2007007911A/es active IP Right Grant
- 2005-12-26 JP JP2006550756A patent/JP4636445B2/ja not_active Expired - Fee Related
- 2005-12-26 BG BG1970U patent/BG1677U1/bg unknown
- 2005-12-26 SK SK5021-2011U patent/SK6196Y1/sk unknown
- 2005-12-27 TW TW094146775A patent/TW200635590A/zh unknown
2007
- 2007-06-12 IL IL183877A patent/IL183877A0/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
RU2397767C2 (ru)	2010-08-27
RU2007128815A (ru)	2009-02-10
BG1677U1 (bg)	2013-04-30
MX2007007911A (es)	2007-08-20
IL183877A0 (en)	2007-10-31
JPWO2006070735A1 (ja)	2008-06-12
ES2387571T3 (es)	2012-09-26
SK50212011U1 (sk)	2012-01-04
JP4636445B2 (ja)	2011-02-23
BRPI0519270A2 (pt)	2009-01-06
CZ23089U1 (cs)	2011-12-19
SK6196Y1 (sk)	2012-08-06

Similar Documents

Publication	Publication Date	Title
EP1728791A4 (en)	2008-12-10	COMPOSITIONS FOR SOLID PHARMACEUTICAL PREPARATION OF SOLIFENACIN OR BZW. A SALT OF IT
NZ591712A (en)	2012-10-26	Imidazopyridazinecarbonitriles useful as kinase inhibitors
GEP201706780B (en)	2017-11-27	Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
MY142029A (en)	2010-08-16	Phenoxyacetic acid derivatives
WO2008131149A3 (en)	2009-06-25	Crystal forms of saxagliptin and processes for preparing same
WO2009098715A3 (en)	2009-10-15	Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
PH12012501817A1 (en)	2013-09-02	Polysubstituted derivatives of 6-heteroaryl-imidazo[1,2-a] pyridines, and preparation and therapeutic use thereof
WO2007065664A3 (en)	2007-08-23	Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors
WO2007138472A3 (en)	2008-02-07	Triazolopyridazine derivatives
WO2010006233A3 (en)	2010-09-10	Foliarly applicable silicon nutrition compositions & methods
TW200732323A (en)	2007-09-01	Organic compounds
MY147262A (en)	2012-11-30	1-aza-bicyclo[3.3.1]nonanes
ATE470443T1 (de)	2010-06-15	Indol-1-yl-essigsäurederivate
NO20076425L (no)	2008-01-30	Fremgangsmater for behandling av drug-resistent cancer
EP1784388B8 (en)	2010-05-19	Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
CY1109366T1 (el)	2014-07-02	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
WO2007005633A3 (en)	2007-05-31	Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
WO2006077025A3 (en)	2006-09-08	Morpholines as 5ht2c agonists
TW200626593A (en)	2006-08-01	Novel compounds
TW200745136A (en)	2007-12-16	4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
WO2006117211A3 (en)	2007-01-11	Urea derivatives methods for their manufacture and uses thereof
PL1869038T3 (pl)	2009-12-31	Podstawione pochodne 5,6,7,8-tetrahydro-imidazo[1,2-a]pirydyn-2-yloaminy i ich zastosowanie do wytwarzania środków leczniczych
WO2008078453A1 (ja)	2008-07-03	血小板産生促進因子及びその利用
TW200635590A (en)	2006-10-16	Stable granular pharmaceutical composition of solifenacin or its salt
TW200833708A (en)	2008-08-16	Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture